MedTrace Logo

Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics

NCT04670627 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2023-05-17

No results posted yet for this study

Summary

The purpose of this study is to analyze nasal samples for the presence of biomarkers of allergic inflammation as well as cold and flu infections, and compare these samples both in and out of an individual's active allergy season. 40 subjects who suffer from seasonal allergies will be recruited and seen both in and out of allergy season, and 10 healthy controls. Nasal epithelial lining fluid (NELF,) collected by placing small filter papers into the nostrils, blood for analysis and a cold/flu swab will be collected at each study visit.

Conditions

  • Seasonal Allergic Rhinitis
  • Rhinovirus

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Neil Alexis, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-22
Primary Completion
2023-04-27
Completion
2023-04-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670627 on ClinicalTrials.gov